Radioiodine therapy offers a curative treatment for feline hyperthyroidism that resolves suffering with a single procedure, yet access barriers prevent many cats from receiving this optimal care.
The welfare case for radioiodine treatment in hyperthyroid cats is compelling: a single procedure cures a condition that would otherwise require daily medication for life or ongoing dietary restriction. The quality of life difference between a cured cat and one managed on daily medication — which can be stressful to administer and requires consistent compliance — is significant. The main barrier to wider use is access: radioiodine facilities require specialist licensing and are not available in all areas. Advocating for expanded access and supporting veterinary specialists who provide this service would improve welfare outcomes for the large population of hyperthyroid cats that could benefit.